Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD

Researchers at UCLA Health uncovered new information about the role inflammation plays in mitigating liver fibrosis, which is associated with metabolic-associated fatty liver disease (MAFLD), one of the most common diseases in the world affecting up to 40 percent of U.S. adults. While…

Click here to view the original article.